$0.1575
-0.0025[-1.56%]
At close: Apr 25
$0.1575
0[0.00%]
PreMarket: 7:29AM EDT
Sonoma Pharmaceuticals
(NASDAQ:SNOA)Sonoma Pharmaceuticals Stock (NASDAQ:SNOA), Earnings Estimates, EPS, and Revenue
Sonoma Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 8
EPS
$-0.080
Quarterly Revenue
$3.1M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$12.3M
Analyze the earnings history of Sonoma Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06/20/2024 | AM | SNOA | Q4 | -$0.31 | — | — | — | $3.01M | — | — | — | Get Alert |
| 02/08/2024 | PM | SNOA | Q3 | -$0.62 | — | -$0.08 | — | $2.94M | — | $3.14M | — | Get Alert |
| 11/13/2023 | PM | SNOA | Q2 | -$0.33 | -$0.24 | -$0.29 | -20.83% | $3.33M | $3.48M | $2.73M | -21.52% | Get Alert |
| 08/10/2023 | PM | SNOA | Q1 | -$0.29 | — | -$0.29 | — | $3.98M | — | $3.43M | — | Get Alert |
| 06/22/2023 | AM | SNOA | Q4 | -$1.07 | — | -$0.31 | — | $2.30M | — | $3.01M | — | Get Alert |
| 02/14/2023 | PM | SNOA | Q3 | -$0.31 | — | -$0.62 | — | $2.90M | — | $2.94M | — | Get Alert |
| 11/14/2022 | PM | SNOA | Q2 | -$0.04 | — | -$0.33 | — | $3.74M | — | $3.33M | — | Get Alert |
| 08/11/2022 | PM | SNOA | Q1 | -$0.52 | — | -$0.29 | — | $3.68M | — | $3.98M | — | Get Alert |
| 07/13/2022 | PM | SNOA | Q4 | -$1.64 | — | -$1.07 | — | $2.16M | — | $2.30M | — | Get Alert |
| 02/11/2022 | PM | SNOA | Q3 | -$0.31 | — | -$0.31 | — | $4.94M | — | $2.90M | — | Get Alert |
| 11/15/2021 | AM | SNOA | Q2 | $0.08 | — | -$0.04 | — | $5.77M | — | $3.74M | — | Get Alert |
| 08/16/2021 | PM | SNOA | Q1 | -$0.38 | — | -$0.52 | — | $5.77M | — | $3.68M | — | Get Alert |
| 07/14/2021 | PM | SNOA | Q4 | -$0.77 | — | -$1.64 | — | $4.58M | — | $2.16M | — | Get Alert |
| 02/16/2021 | PM | SNOA | Q3 | -$0.72 | — | -$0.31 | — | $4.68M | — | $4.94M | — | Get Alert |
| 11/20/2020 | PM | SNOA | Q2 | -$0.91 | — | $0.08 | — | $4.97M | — | $5.77M | — | Get Alert |
| 08/14/2020 | PM | SNOA | Q1 | — | — | $0.02 | — | $4.71M | — | $7.25M | — | Get Alert |
| 07/10/2020 | PM | SNOA | Q4 | -$2.45 | — | -$0.77 | — | $4.38M | — | $4.58M | — | Get Alert |
| 02/14/2020 | PM | SNOA | Q3 | -$0.26 | — | -$0.72 | — | $5.28M | — | $4.68M | — | Get Alert |
| 11/14/2019 | PM | SNOA | Q2 | -$3.93 | — | -$0.91 | — | $4.94M | — | $4.97M | — | Get Alert |
FAQ
When is Sonoma Pharmaceuticals (NASDAQ:SNOA) reporting earnings?
Sonoma Pharmaceuticals (SNOA) is scheduled to report earnings on June 20, 2024. The last reported earnings were for reported on February 8, 2024 for Q3.
What were the latest earnings per share (EPS) for Sonoma Pharmaceuticals (NASDAQ:SNOA)?
The Actual EPS was $-0.08, which missed the estimate of $0.00.
What were Sonoma Pharmaceuticals’s (NASDAQ:SNOA) revenues?
The Actual Revenue was $3.1M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.